“…The major disadvantages of these methods include, less sensitivity [11] , more sample volume (>0.25 mL) [11] , [13] , [14] , [19] , longer chromatographic run time (>4 min) [11] , [12] , [13] , [14] , [15] , [16] , [17] , [18] , complex with derivatization and expensive automated extraction procedure [13] , [18] , and narrow linearity range not suitable for bioequivalence/pharmacokinetic application in humans at higher dose (0.1–30 ng/mL) [13] , [14] . Similarly, numerous LC/MS/MS methods are described in the literature to determine amlodipine in different biological fluids [19] , [20] , [21] , [22] , [23] , [24] , [25] , [26] , [27] , [28] , [29] , [30] , [31] . Among the applied methods, either the chromatographic run time was long (>4 min) [19] , [20] , [22] , [24] , [25] , [30] , [31] , the plasma volume was high (>0.25 mL) [19] , [21] , [22] , [23] , [24] , [25] , [30] or the method was insensitive for bioequivalence/pharmacokinetic application [20] , [23] , [25] , [27] , [30] , [31] .…”